Optiscan has been featured in Stockhead, The Australian, and 11 News Corp mastheads following the launch of InForm™, our next-generation imaging device designed to revolutionize digital pathology and accelerate diagnostics.

The article highlights how InForm™ digitizes pathology workflows by providing real-time, high-resolution imaging at the point of care, reducing reliance on traditional slide preparation. By enabling immediate digital insights from tissue samples, InForm™ enhances efficiency, precision, and accessibility in pathology and laboratory medicine.

With the global anatomic pathology market projected to reach US$53.27 billion by 2031, Optiscan is driving the shift toward digital pathology with cutting-edge imaging solutions. Commenting on this advancement, CEO Dr. Camile Farah stated:

"Through InForm, Optiscan is reshaping traditional practices, enabling faster, more accurate decision-making, and supporting a seamless transition to digital pathology,” Optiscan said in its unveiling announcement to the market."

Stockhead – Read the full article here.
The Australian – Read the full article here.